Lapatinib Antagonizes Multidrug Resistance–Associated Protein 1–Mediated Multidrug Resistance by Inhibiting Its Transport Function

Por Ma, Shao-lin, Hu, Ya-peng, Wang, Fang, Huang, Zhen-cong, Chen, Yi-fan, Wang, Xiao-kun, Fu, Li-wu
Publicado em 2014

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro

Por Yan, Yan-Yan, Wang, Fang, Zhao, Xiao-Qin, Wang, Xiao-Kun, Chen, Yi-Fan, Liu, Hong, Xie, Yong, Fu, Li-Wu
Publicado no Oncol Rep (2017)

Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo

Por Wang, Xiao-kun, Kin Wah To, Kenneth, Huang, Li-yan, Xu, Jing-hong, Yang, Ke, Wang, Fang, Huang, Zhen-cong, Ye, Sheng, Fu, Li-wu
Publicado no Oncotarget (2014)

Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein

Por Zhou, Wen-jing, Zhang, Xu, Cheng, Chao, Wang, Fang, Wang, Xiao-kun, Liang, Yong-ju, To, Kenneth Kin Wah, Zhou, Wang, Huang, Hong-bing, Fu, Li-wu
Publicado em 2012

BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells

Por He, Dan, Zhao, Xiao-qin, Chen, Xing-gui, Fang, Yi, Singh, Satyakam, Talele, Tanaji T., Qiu, Hui-juan, Liang, Yong-ju, Wang, Xiao-kun, Zhang, Guo-qing, Chen, Zhe-sheng, Fu, Li-wu
Publicado em 2013